Business
China SXT Pharmaceuticals, Inc. Receives National High-tech Enterprise Qualification
TAIZHOU, China, Apr. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the "Company") (NASDAQ:SXTC), a specialty pharmaceutical company focusing on the
About this update from China Sxt Pharmaceuticals, Inc.
[{"type":"text","content":"TAIZHOU, China, Apr. 2, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (the \"Company\") (NASDAQ:SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (\"TCMPs\"), announced today that its VIE subsidiary, Jiangsu Suxuantang Pharmaceutical Co., Ltd. (\"Taizhou Suxuantang\"), has been certified as National High-tech Enterprise (the \"Certification\") by the Ministry of Science and Technology of the PRC. The Certification is valid for three years and allows Taizhou Suxuantang to enjoy a preferential income tax rate of 15% versus the standard rate of 25%.\nAbout China SXT Pharmaceuticals, Inc. \nIncorporated in 2005 and headquartered in Taizhou City, Jiangsu Province, China, China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company based focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, which is a type of Traditional Chinese Medicine that has been processed to be ready for use. For more information, please visit www.sxtchina.com. \nSafe Harbor Statement\nThis press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as \"may, \"will, \"intend,\" \"should,\" \"believe,\" \"expect,\" \"anticipate,\" \"project,\" \"estimate\" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; the growth of the pharmaceutical market, particularly the Traditional Chinese Medicine Pieces (\"TCMPs\") market, in China; reputation and...